Back to search
FDAFDA · Food and drugs·Recall number Z-1603-2024

IBA Proton Therapy System - PROTEUS 235, PTS-10 versions, PTS-11 versions, and PTS-12 versions.

Published May 1, 2024 · Recall initiated: March 4, 2024

Summary

FDA records medical device Class II recall Z-1603-2024, published May 1, 2024 and initiated March 4, 2024. Recalling firm: Ion Beam Applications S.A.; Status: Ongoing; Reported quantity: 8 units; Lot: PTS-10 versions, PTS-11 versions, and PTS-12 versions. UDI-DI: 05404013801138; Serial Numbers: SAT.123, SAT.126, SAT.133, SAT.140, SBF.105, SBF.113, SBF.128, SBF.135. All configurations. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a risk of mistreatment as irradiation is not prevented when some safety parameters are out of tolerance.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ion Beam Applications S.A.
Distributor
US Nationwide distribution in the states of AR, FL, LA, KS, MI, TX, VA.
Lot
PTS-10 versions, PTS-11 versions, and PTS-12 versions. UDI-DI: 05404013801138; Serial Numbers: SAT.123, SAT.126, SAT.133, SAT.140, SBF.105, SBF.113, SBF.128, SBF.135. All configurations.
Risk classification
Class II
Area (FDA)
device
Country
Belgium

Related recalls

Questions about this recall

Was IBA Proton Therapy System - PROTEUS 235, PTS-10 versions, PTS-11 versions, and PTS-12 versions. recalled?

Yes. FDA published recall Z-1603-2024 on May 1, 2024. Reported hazard: There is a risk of mistreatment as irradiation is not prevented when some safety parameters are out of tolerance.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail